New MammoScreen® AI Enhances Breast Cancer Screening with Comprehensive Workflow Features

New MammoScreen® AI delivers a comprehensive suite of features including breast density and pre-reporting, creating the ultimate ...

October 11, 2024 | Friday | News
Andelyn Biosciences Partners with Hubble Therapeutics to Advance Gene Therapy for Rare Childhood Blindness

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been s...

October 11, 2024 | Friday | News
Basilea Pharmaceutica Secures $1.25 Million Milestone Payment Following Strong Sales of Cresemba® in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and ...

October 10, 2024 | Thursday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
Ex-Pfizer Titans Stand Firm, Defiantly Back CEO Amid Activist Investor Storm, Betting on a Bold Long-Term Gamble for Shareholder Value

In an exclusive statement released through Guggenheim Securities, LLC, former Pfizer CEO Ian Read and former CFO Frank D’Amelio addressed growing s...

October 10, 2024 | Thursday | Analysis
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News
Roche Survey Reveals Half of Global Respondents Unaware of HPV’s Link to Cervical Cancer, Urging Immediate Action

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with ne...

October 08, 2024 | Tuesday | Reports
PROCEPT BioRobotics Launches FDA-Approved Trial Comparing Aquablation to Prostatectomy for Cancer Treatment

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate C...

October 08, 2024 | Tuesday | News
Global TB Summit 2024: QIAGEN’s QuantiFERON®-TB Gold Plus Blood Test at the Forefront of Latent TB Detection and Global Disease Control

QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in ...

October 08, 2024 | Tuesday | News
NovaCina Expands Perth Facility with Advanced SA25 GMP Filling Line to Enhance Global CDMO Services

NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with...

October 08, 2024 | Tuesday | News
Americans Victor Ambros and Gary Ruvkun Win Nobel Prize in Medicine for Landmark Discovery of microRNA

The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microR...

October 07, 2024 | Monday | News
BD Partners with ten23 Health to Enhance Prefillable Syringe Traceability with RFID Technology

 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ten23 health, the human-centri...

October 07, 2024 | Monday | News
Enzene Launches Advanced EnzeneX™ 2.0 Platform at CPHI Milan

Enzene, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced it is to launch its new EnzeneX&trad...

October 07, 2024 | Monday | News
Eli Lilly Invests $4.5 Billion in Medicine Foundry to Transform Drug Development and Manufacturing in Indiana

Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale glo...

October 07, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close